Progress of Mild Alzheimer’s Disease in Patients on Solanezumab versus Placebo

Update Il y a 4 ans
Reference: EUCTR2013-001119-54

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To test the hypothesis that solanezumabwill slow the cognitive and functional decline of AD as compared with placebo in patients with mild AD.


Inclusion criteria

  • MILD ALZHEIMER’S DISEASE